NCT04182919View on ClinicalTrials.gov

"Efficacy and Safety of Phlai Capsule Compared to Placebo as the Treatment in Allergic Rhinitis Patients"

PHASE3CompletedINTERVENTIONAL
Enrollment

267

Participants

Timeline

Start Date

January 31, 2020

Primary Completion Date

December 20, 2021

Study Completion Date

December 20, 2021

Conditions
Allergic Rhinitis
Interventions
DRUG

Phlai

Each capsule contains 4 mg compound D. Using orally in the evening everyday in 4 weeks

DRUG

Placebo oral capsule

Like Phlai capsule extract : :PVP K30, Calcium carbonate, Dibasic calcium phosphate, Sodium starch glycolate, Colloidal silicon dioxide, Ethanol 96%, Purified water, Magnesium stearate. Not having compound D. Using orally in the evening everyday in 4 weeks

Trial Locations (1)

10330

Minh Phuoc Hoang, MD, Bangkok

Sponsors
All Listed Sponsors
collaborator

Government Pharmaceutical Organization

UNKNOWN

lead

Chulalongkorn University

OTHER